Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
503468-95-9
|
| gptkbp:hasMolecularFormula |
C19H23N5O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
NU7441
|
| gptkbp:inhibitedBy |
DNA-dependent protein kinase (DNA-PK)
|
| gptkbp:is_administered_in |
preclinical research
|
| gptkbp:IUPACName |
2-(4-morpholinyl)-8-oxo-8,9-dihydro-7H-pyrido[2,3-d]pyrimidin-7-yl)-N,N-dimethylacetamide
|
| gptkbp:meltingPoint |
>200°C
|
| gptkbp:molecularWeight |
369.42 g/mol
|
| gptkbp:PubChem_CID |
9903786
CHEMBL180086 |
| gptkbp:synonym |
KU-57788
|
| gptkbp:usedFor |
potential radiosensitizer in cancer therapy
research tool in DNA repair studies |
| gptkbp:bfsParent |
gptkb:DNA-PK
|
| gptkbp:bfsLayer |
6
|